GCG and cardiovascular disorder: Advancement of traditionally cardiovascular medicine such as glucagon-like peptide-1 (GLP-1) analogues in treatment of PD, for example, suggests that cardiovascular diseases and PD may share similar pathophysiologic aspects, enhancing the need to address CV risk factors in patients with PD32,33.